Developing a blood-based diagnostic approach for sarcoidosis, founded on research conducted at a leading medical university.
Watch Our Introduction
A brief video description of our mission and approach
Our Mission
Millions of people live with inflammatory diseases that are difficult to diagnose. At Anaxa, we are working to change that.
Watch Our Introduction
A brief video description of our mission and approach
The Challenge
Sarcoidosis is a systemic inflammatory disease that can affect multiple organs, most commonly the lungs and lymph nodes. It is characterized by the formation of granulomas—organized clusters of immune cells—that may interfere with normal organ function.
Despite its impact, there is no single definitive test for sarcoidosis. Diagnosis typically relies on a combination of clinical assessment, imaging, laboratory tests, and invasive procedures such as biopsies.
Learn About SarcoidosisLungs, lymph nodes, heart, eyes, liver, skin
No single definitive test available
Biopsies often required
Late diagnosis impacts outcomes
Our Solution
Through extensive analysis of patient samples at Karolinska Institutet, our research team identified a distinct immunological signal. Biomarker 143 was found to be significantly elevated in patients with sarcoidosis.
Based on this discovery, Anaxa is developing a non-invasive diagnostic blood test designed to support earlier and more reliable diagnosis.
Simple, non-invasive blood draw
Detection of Biomarker 143
Supporting clinical evaluation of suspected sarcoidosis
Scientific Foundation
Anaxa is a spin-off from the Karolinska Institutet, one of the world's leading medical research institutions. Our work builds on cutting-edge research in translational immunology.
Our research originates from studies conducted at one of the world's leading medical universities, focusing on immune mechanisms and Biomarker 143 in sarcoidosis.
About Our ResearchThrough analysis of extensive patient cohorts, Biomarker 143 was identified as being associated with sarcoidosis and confirmed using multiple analytical platforms.
Our ApproachOur team combines deep academic expertise in immunology with strategic business experience, bridging scientific discovery and diagnostic development.
Meet the TeamFor inquiries regarding Anaxa, partnership opportunities, or our research activities, we welcome you to get in touch. Whether you're a researcher, clinician, or potential partner, we'd love to hear from you.